Oncotarget

Research Papers:

Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancer

Alisa A. Petkevich _, Aleksandr A. Abramov, Vadim I. Pospelov, Natalya A. Malinina, Elena I. Kuhareva, Natalya V. Mazurchik and Olga I. Tarasova

PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Oncotarget. 2021; 12:1697-1706. https://doi.org/10.18632/oncotarget.28036

Metrics: PDF 143 views  |   Full Text 526 views  |   ?  


Abstract

Alisa A. Petkevich1, Aleksandr A. Abramov1, Vadim I. Pospelov1, Natalya A. Malinina2, Elena I. Kuhareva2, Natalya V. Mazurchik2 and Olga I. Tarasova2

1 Genetic Research Laboratory of Advanced Therapy Department, Peoples’ Friendship University of Russia (RUDN University), Moscow, Russian Federation

2 Advanced Therapy Department, Peoples’ Friendship University of Russia (RUDN University), Moscow, Russian Federation

Correspondence to:

Alisa A. Petkevich, email: pa.alisa26@gmail.com

Keywords: microvesicles; miRNA; cirrhosis; liver cancer; saliva

Received: March 08, 2021     Accepted: July 13, 2021     Published: August 17, 2021

Copyright: © 2021 Petkevich et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ABSTRACT

Patients with HCV-related cirrhosis are at risk for liver cancer development. For these patients miRNAs may serve as preclinical markers, which expression levels are deregulated in cancer and which are stable to the damaging factors partly through complex formation with proteins or packaging into exosomes. In this research we have tried to identify what miRNA fraction in plasma – exosomal or not packed into exosomes (non-exosomal) – is stronger associated with primary liver cancer. The second question was whether saliva miRNA expression levels – both exosomal and non-exosomal – are associated with primary liver cancer. We evaluated exosomal and non-exosomal miRNAs – let-7a-5p, -16-5p, -18a-5p, -21-5p, -22-3p, -34a-5p, -103a-3p, -122-5p, -221-3p, -222-3p – in plasma and saliva of patients with HCV-related liver cirrhosis (n = 24), primary liver cancer (n = 24) and healthy volunteers (n = 21). Relative expression level was calculated with normalization of exosomal miRNA to exosomal miRNA-16-5p, non-exosomal miRNA to non-exosomal miRNA-16-5p and as a ratio of exosomal miRNA to non-exosomal miRNA. In this study, non-exosomal miRNAs (let-7a, miRNA-21-5p, -22-3p, -103a, -122-5p, -221-3p and 222-3p) normalized to non-exosomal miRNA-16-5p showed strong association with liver cancer in plasma. Three miRNAs, those with the mostly pronounced change of expression levels in plasma, – miRNA-21-5p, 122-5p, 221-3p – were detected in saliva. In contrast, exosomal miRNAs show stronger association with primary liver over non-exosomal miRNAs when working with saliva. Thus, depending on the examined biological material both miRNA fractions may serve as a valuable source for diagnostic and prognostic data.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 28036